| Price | $3.76 |
| Year Range | $2.44 - $4.59 |
| Target Price | Sign up |
| Volume | 258,540 |
| Market Cap | $341M |
| Dividend Yield | 0% |
| Industry | Biotechnology |
AI stock analysis for Trevi Therapeutics
Welcome to our AI-driven stock analysis tool, where sophisticated technology meets comprehensive market data to empower your investment decisions. Focusing on Trevi Therapeutics , our platform leverages the advanced capabilities of Chat GPT to meticulously analyze a wealth of information from AltIndex. This includes in-depth fundamental data, technical analysis, and a range of alternative data sources. By integrating these diverse datasets, Chat GPT provides a nuanced and insightful stock analysis, offering you a well-rounded recommendation based on its extensive knowledge and real-time market insights.
Access to our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
